feedback

Faculty

William G. Wierda, MD, PhD
William G. Wierda, MD, PhD
Professor, Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX


Anas Younes, MD
Anas Younes, MD
Professor of Medicine
Department of Lymphoma/Myeloma
Director, Clinical and Translational Research
Program Chief, Lymphoma Service
Memorial Sloan-Kettering Cancer Center
New York, NY


Accredited By

Physicians’ Education Resource®, LLC

Resources

Click here for additional educational resources for this activity.

Activity Details

Credit Type: AMA PRA Category 1 Credits
Credit Amount: 2.0
Release Date: May 29, 2014
Expiration Date: May 29, 2015
Estimated Time to Complete Activity: 2.0 hours
Fee for Activity: Free of Charge

Activity Description

The Clinical Vignettes series is a collection of online clinical case presentations, which focus on an interesting or challenging patient encounter, with the goal of reviewing the treatment decision-making process for the practicing community-based oncologist/hematologist.

This series will focus on mantle cell lymphoma (MCL), follicular lymphoma (FL), and chronic lymphocytic leukemia (CLL).

Agenda

Topics for discussion include older patients with the following hematologic malignancies:

  • Mantle cell lymphoma
  • Follicular lymphoma
  • Chronic lymphocytic leukemia

Learning Objectives

At the conclusion of this activity, participants should be better prepared to:

  • Assess how new data can be incorporated into individualized treatment plans for patients with hematologic malignancies, based upon an evaluation of efficacy and safety and consideration of patient characteristics, such as age and performance status
  • Apply risk-adaptive management strategies that incorporate prognostic factors, along with medical fitness status and other patient characteristics, into treatment planning
  • Describe adverse events common to guideline-recommended treatment regimens

Target Audience

This online activity is directed toward community-based medical oncologists/hematologists and fellows who treat patients with hematologic malignancies.

Requirements for Successful Completion

In order to receive a CME certificate, participants must read through the Clinical Vignettes Series: Hematologic Malignancies cases, listen to the audio, and complete the post-test, the evaluation, and request for credit. Participants may immediately download a CME certificate upon completion of these steps.

Media

Internet-based

Conflict of Interest Policy / Disclosure Statement

The following individuals have relevant financial relationships with commercial interests to disclose:

William G. Wierda, MD, PhD – Grant/Research Support: Genentech, Abbott Pharmaceuticals, GlaxoSmithKline
Consultant: Genentech, Abbott Pharmaceuticals, GlaxoSmithKline, Pharmacyclics, Gilead, Celgene

Anas Younes, MD – Grant/Research Support: Novartis, Johnson & Johnson, Seattle Genetics, Merck, Genentech, Infinity, Gilead
Honoraria: Novartis, Seattle Genetics, Millennium, Celgene, Curis, sanofi-aventis, Pharmacyclics, Incyte

The following individuals have no relevant financial relationships with commercial interests to disclose: Physicians' Education Resource®, LLC, Planning Staff – Dru Dace, PhD, Francie Jallad, and David Lee, PhD

Accreditation Statement for Physicians

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Statement of Commercial Support

This activity is supported by an educational grant from Genentech.

Designation of Credit

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclaimer Statement

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians’ Education Resource®, LLC, or the company that provided commercial support for this CME activity.

Disclosure of Unlabeled Use

This CME activity may contain discussions about off-label/unapproved uses of drugs. For additional information about approved uses, including approved indications, contraindications, and warnings, participants are advised to consult prescribing information for all products discussed or consult the Physicians’ Desk Reference. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.

Contact Information for Questions About the Activity

Physicians' Education Resource®, LLC
666 Plainsboro Road, Suite 356
Plainsboro, NJ 08536
Phone: (888) 949-0045
E-mail: info@gotoper.com

Hardware / Software Requirements

OpenCME recommends using the latest versions of these supported browsers: Google Chrome, Mozilla Firefox, Safari; and Microsoft Internet Explorer versions 8, 9, or 10. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.

Download From the ITunes App Store now!

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.